Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022

SELL
$2.33 - $3.37 $30,290 - $43,810
-13,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$2.52 - $2.99 $12,600 - $14,950
-5,000 Reduced 27.78%
13,000 $36,000
Q2 2021

Jul 29, 2021

BUY
$2.6 - $3.65 $7,800 - $10,950
3,000 Added 20.0%
18,000 $51,000
Q1 2021

May 14, 2021

BUY
$2.73 - $4.5 $40,950 - $67,500
15,000 New
15,000 $51,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Brown Advisory Securities, LLC Portfolio

Follow Brown Advisory Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.